Genpax logo

Genpax

Connecting Pathogen Genomics

38 employees · est. 2021 · London, United Kingdom

VS
Mytos logo

Mytos

Scaling Regenerative Medicines to Millions of Patients

48 employees · est. 2016 · London, United Kingdom

Mytos is the older company (2021 vs 2016).

Side-by-Side Comparison

Genpax Mytos
Founded
2021 2016 older
Headquarters
London, United Kingdom London, United Kingdom
Employees
38 48
Industry
Analytics, Biotechnology Not tracked yet
Funding Stage
Seed Series A
Total Funding
$2.70M $20.93M
Funding Rounds
1 5
Services
Whole Genome Sequencing Analysis Platform Automated manufacturing of regenerative medicine products, Process & Analytical Development, Regulatory Support, Cost-efficient production solutions
Target Customers
Healthcare Systems, Governments, Industry Biotech companies, Clinical-stage pharmaceutical companies, Research institutions working on regenerative medicine
Taxonomy
Genome Sequencing, Infectious Disease, Precision Genomics, Bacterial Isolates, Strain Identification, Outbreak Management, Transmission Events, Clinical Significance, Biotech, Medtech, Healthtech Regenerative Medicine, Stem Cell Therapy, Automated Manufacturing, IDEM Robotics Platform, CDMO (Contract Development And Manufacturing Organization), Parkinson's Treatment, Bone Repair, Blindness Treatment, Hearing Loss Treatment, Biotech Engineering, Hardware Development, Software Development, Mechanical Engineering
Website
genpax.co mytos.bio
Genpax logo

About Genpax

Genpax is a pioneering startup in the United Kingdom that is disrupting the field of infectious disease investigation with its groundbreaking surveillance tool, IDEM. Utilizing whole genome sequencing analysis, IDEM employs precision genomics to reveal the true relationship between bacterial isolate...

Mytos logo

About Mytos

Mytos, founded in 2016 and headquartered in the United Kingdom, is at the forefront of scaling regenerative medicines to millions of patients. Their innovative iDEM robotics platform sits at the heart of a cutting-edge automated CDMO process, aiming to provide stem cell-derived therapies at a low co...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Genpax and Mytos — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Genpax and Mytos — by email.

Frequently Asked Questions

Genpax — Connecting Pathogen Genomics . Mytos — Scaling Regenerative Medicines to Millions of Patients. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Genpax has raised $2.70M while Mytos has raised $20.93M.
Genpax and Mytos operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Genpax with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy